LEADER 05380nam 2200673Ia 450 001 996208645803316 005 20230721004942.0 010 $a1-282-03456-1 010 $a9786612034565 010 $a1-61583-455-9 010 $a1-4443-0164-0 010 $a1-4443-0165-9 035 $a(CKB)1000000000715987 035 $a(EBL)416460 035 $a(OCoLC)436923140 035 $a(SSID)ssj0000203006 035 $a(PQKBManifestationID)11196389 035 $a(PQKBTitleCode)TC0000203006 035 $a(PQKBWorkID)10274758 035 $a(PQKB)10988251 035 $a(MiAaPQ)EBC416460 035 $a(EXLCZ)991000000000715987 100 $a20080613d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMilk processing and quality management$b[electronic resource] /$fedited by Adnan Tamime 210 $aChichester, West Sussex ;$aAmes, Iowa $cBlackwell Pub.$d2008 215 $a1 online resource (344 p.) 225 1 $aSociety of Dairy Technology series 300 $aDescription based upon print version of record. 311 $a1-4051-4530-7 320 $aIncludes bibliographical references and index. 327 $aMilk Processing and Quality Management; Contents; Preface to Technical Series; Preface; Contributors; 1 On-Farm Hygienic Milk Production; 1.1 Introduction; 1.2 Sources of microbial contamination of bulk tank milk; 1.2.1 Background; 1.2.2 Mastitis; 1.2.3 Environment; 1.2.4 Milking equipment; 1.2.5 Microbial growth during milk storage; 1.3 Control of microbial contamination of bulk tank milk; 1.3.1 Good farming practice; 1.3.2 Animal health management; 1.3.3 Control of feed; 1.3.4 Facility hygiene; 1.3.5 Milking operations; 1.3.6 Milking machine design and operations 327 $a1.3.7 Bulk tank design and operations1.3.8 Identification of effective control measures; 1.4 Future developments in handling of the milk on the farm; 1.4.1 Concentration of milk; 1.4.2 Heat treatment of the milk; 1.4.3 In/online monitoring of bulk tank milk quality; 1.5 Conclusions; References; 2 Properties and Constituents of Cow's Milk; 2.1 Introduction; 2.2 Milk composition; 2.3 Milk constituents; 2.3.1 Lactose; 2.3.2 Milk salts; 2.3.3 Lipids; 2.3.4 Proteins; 2.3.5 Indigenous milk enzymes; 2.4 Heat-induced changes in physicochemical properties of milk; 2.4.1 pH; 2.4.2 Buffering capacity 327 $a2.4.3 Creaming2.5 Heat-induced changes in processing characteristics of milk; 2.5.1 Rennet-induced coagulation; 2.5.2 Acid-induced coagulation; 2.5.3 Heat-induced coagulation; 2.6 Relationship between the quality of raw milk and that of products; 2.7 Conclusions; References; 3 Microbiology of Raw and Market Milks; 3.1 Introduction; 3.2 Microflora of raw milk; 3.2.1 Spoilage organisms; 3.2.2 Pathogenic organisms; 3.3 Microflora of pasteurised milk; 3.3.1 Spoilage organisms; 3.3.2 Pathogenic organisms; 3.4 Microflora of UHT milk; 3.4.1 Heat-resistant spore-formers 327 $a3.4.2 Post-sterilisation contaminants3.5 Microflora of ESL milk; 3.6 Sources of contamination; 3.6.1 Raw milk; 3.6.2 Pasteurised milk; 3.6.3 UHT milk; 3.7 Measures to reduce bacterial contamination of raw and market milks; 3.7.1 Cleaning and sanitation; 3.7.2 Cooling the milk during storage; 3.7.3 Addition of carbon dioxide; 3.7.4 Applications of bio-preservatives; 3.7.5 Thermal treatments; 3.7.6 Non-thermal treatments; 3.7.7 Multitarget attack/integrative approaches; 3.8 Conclusion; References; 4 Quality Control; 4.1 Introduction; 4.2 Quality control of raw milk 327 $a4.3 Quality control of processed milk4.4 Methods of analysis; 4.4.1 Analysis of abnormal milk; 4.4.2 Microbial analysis; 4.4.3 Mastitic milk - somatic cell count (SCC); 4.4.4 Testing for residues compounds; 4.5 Major components analysis; 4.5.1 Protein composition analysis; 4.5.2 Fat composition analysis; 4.5.3 Analysis of other milk components; 4.5.4 Analysis of degradation products formed during milk storage; 4.5.5 Evaluation of heat load; 4.6 Analysis of fraudulent addition of ingredients and authentication; 4.6.1 Addition of water; 4.6.2 Addition of whey proteins 327 $a4.6.3 Addition of non-dairy proteins 330 $aThe Society of Dairy Technology (SDT) has joined with Wiley-Blackwell to produce a series of technical dairy-related handbooks providing an invaluable resource for all those involved in the dairy industry; from practitioners to technologists working in both traditional and modern large-scale dairy operations. The fifth volume in the series, Milk Processing and Quality Management, provides timely and comprehensive guidance on the processing of liquid milks by bringing together contributions from leading experts around the globe. This important book covers all major aspects of hygienic milk pr 410 0$aSociety of Dairy Technology series. 606 $aDairy processing$xQuality control 606 $aDairying 615 0$aDairy processing$xQuality control. 615 0$aDairying. 676 $a637.1 676 $a637/.1 686 $aLAN 820f$2stub 686 $aWIR 896f$2stub 701 $aTamime$b A. Y$0532650 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996208645803316 996 $aMilk processing and quality management$92245944 997 $aUNISA LEADER 04894nam 22007455 450 001 9910754097503321 005 20251009073509.0 010 $a981-9965-64-0 024 7 $a10.1007/978-981-99-6564-9 035 $a(CKB)28550565900041 035 $a(MiAaPQ)EBC30825242 035 $a(Au-PeEL)EBL30825242 035 $a(DE-He213)978-981-99-6564-9 035 $a(PPN)272915475 035 $a(EXLCZ)9928550565900041 100 $a20231024d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvanced Drug Delivery $eMethods and Applications /$fedited by Tuhin Subhra Santra, Ashwini Uma Surendra Shinde 205 $a1st ed. 2023. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2023. 215 $a1 online resource (368 pages) 225 1 $aStudies in Mechanobiology, Tissue Engineering and Biomaterials,$x1868-2014 ;$v26 311 08$a9789819965632 320 $aIncludes bibliographical references. 327 $aChapter 1. Biological methods -- Chapter 2. Liposomal based drug delivery system -- Chapter 3. Hydrogel-based drug delivery strategies -- Chapter 4. Monoclonal antibodies -- Chapter 5. Electroporation -- Chapter 6. Photoporation -- Chapter 7. Mechanoporation -- Chapter 8. Magnetoporation -- Chapter 9. Microinjection -- Chapter 10. Jet injection -- Chapter 11. Sonoporation -- Chapter 12. Device based drug delivery techniques ? microfluidics Chapter 13. Nanoparticles drug delivery systems -- Chapter 14. BioMaterials -- Chapter 15. Implanted drug delivery systems -- Chapter 16. Transdermal drug delivery systems -- Chapter 17. Subcutaneous drug delivery systems -- Chapter 18. Nasopulmonary drug delivery systems -- Chapter 19. Mucosal drug delivery systems -- Chapter 20. Intrauterine drug delivery systems -- Chapter 21. Gastro retentive drug delivery systems -- Chapter 22. Endoscopic assisted drug delivery -- Chapter 23. Theranostics. 330 $aThis book provides an overview of various drug delivery systems at the cellular level including biological, chemical methods, and most importantly physical methods such as photoporation, electroporation, mechanoporation, and device-based techniques (e.g., microfluidics), as well as organism-level techniques including nanomaterials, biomaterials, and transdermal. Drug delivery (DD) can be defined as the method and route by which an active pharmaceutical ingredient (API) is administered to promote its desired pharmacological effect and/or convenience and/or to reduce adverse effects. Drug delivery systems are developed to maximize drug efficacy and minimize side effects. As drug delivery technologies improve, the drug becomes safer and more comfortable for patients to use. During the last seven decades, extraordinary progress has been made in drug delivery technologies, such as systems for long-term delivery for months and years, localized delivery, and targeted delivery. The advances, however, will face the next phase considering the future technologies that we need to overcome many physicochemical barriers for new formulation development and biological unknowns for treating various diseases. Thus, various technologies are built at a single-cell level as well as an organism level. This book is useful at the university level for graduate courses or research studies and biotechnology-based companies with research and development on cell-based analysis, diagnosis, or drug screening. This book is also very useful for researchers in drug delivery technologies, which came in frontier research for the past decade. 410 0$aStudies in Mechanobiology, Tissue Engineering and Biomaterials,$x1868-2014 ;$v26 606 $aDrug delivery systems 606 $aBiomedical engineering 606 $aNanobiotechnology 606 $aMicrofluidics 606 $aCytology 606 $aPharmaceutical chemistry 606 $aDrug Delivery 606 $aBiomedical Engineering and Bioengineering 606 $aNanobiotechnology 606 $aMicrofluidics 606 $aCell Biology 606 $aPharmaceutics 615 0$aDrug delivery systems. 615 0$aBiomedical engineering. 615 0$aNanobiotechnology. 615 0$aMicrofluidics. 615 0$aCytology. 615 0$aPharmaceutical chemistry. 615 14$aDrug Delivery. 615 24$aBiomedical Engineering and Bioengineering. 615 24$aNanobiotechnology. 615 24$aMicrofluidics. 615 24$aCell Biology. 615 24$aPharmaceutics. 676 $a615.6 702 $aSantra$b Tuhin Subhra 702 $aShinde$b Ashwini Uma Surendra 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910754097503321 996 $aAdvanced Drug Delivery$93595700 997 $aUNINA LEADER 05656nam 22006255 450 001 9910585595203321 005 20220729113935.0 010 $a9783839461969 010 $a3839461960 024 7 $a10.1515/9783839461969 035 $a(CKB)5700000000101077 035 $a(DE-B1597)619187 035 $a(DE-B1597)9783839461969 035 $a(ScCtBLL)5d8c6c74-b31f-45a5-8d9f-ede20c5fbb58 035 $a(OCoLC)1334107008 035 $a(oapen)doab90621 035 $a(EXLCZ)995700000000101077 100 $a20220729h20222022 fg 101 0 $ager 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPatientenpolitiken $eZur Genealogie eines kollektiven Subjekts /$fHelene Gerhards 210 $ctranscript Verlag$d2022 210 1$aBielefeld : $ctranscript Verlag, $d[2022] 210 4$d©2022 215 $a1 online resource (518 p.) 225 0 $aEdition Politik ;$v131 327 $tFrontmatter -- $tInhalt -- $tDanksagung -- $t1 Einleitung -- $t2 Patienten als soziale und politische Kollektive: Der Forschungsstand -- $t2.1 Gesundheit, Krankheit, biologischer Körper: Beiträge aus der Bewegungsforschung -- $t2.2 Autonomie, Vertrauen, Gerechtigkeit: Patientenkollektive in der angewandten (Bio-)Ethik und sozialphilosophischen Diskussion -- $t2.3 Wissenschaft, Gesellschaft, Politik: Patientenorganisationen aus der Perspektive der Science and Technology Studies -- $t2.4 Biosozialität und biologische Bürgerschaft: Patienten als kollektive Subjekte im biomedizinischen Zeitalter -- $t2.5 Bewertung des analytischen Angebots: Von Spuren der transformativen Patientenfigur auf dem Weg zu einer genealogischen und subjektkonstitutionsorientierten Analyse von Patientenschaft -- $t3 Der theoretisch-methodologische Zugang -- $t3.1 Die Genealogie als Rahmenuntersuchung -- $t3.2 ?Subjekte analysieren? -- $t3.3 Integration der Ergebnisse: Die genealogische Subjektkonstitutionsanalyse -- $t3.4 Methodologischer Umgang mit dem Forschungsmaterial und hermeneutisch-inhaltsanalytische Vorgehensweise der Subjektkonstitutionsanalyse -- $t4 Der Patient als individuelles Subjekt: Der Patient der ?Moderne? -- $t4.1 Foucaults Die Geburt der Klinik: Das Subjektkonzept der Diagnostik und der Patient als Individuum -- $t4.2 Die Konstitution des Patientensubjekts in der Medizinsoziologie Talcott Parsons? -- $t4.3 Zusammenfassung -- $t5 Transformationen: Patientengeschichtsschreibung als Einführung einer ?subjektivierten? Patientenkonzeption -- $t5.1 Das Verschwinden des kranken Menschen aus der geschichtlichen Gesellschaft und die Kritik der modernen medizinischen Praxis -- $t5.2 Medizingeschichte ?von unten? und die Ausgrabung des Patientenblicks -- $t5.3 Geschichtspolitik und Theoriepolitik: Eine Aporie -- $t6 Das Patientensubjekt des Kollektivs: Die radikale Politisierung der Krankheit -- $t6.1 Patientensubjektkonzepte der (Anti-)Psychiatrie -- $t6.2 Das Sozialistische Patientenkollektiv Heidelberg (SPK): Ein politisches Projekt der Krankheit -- $t6.3 Zusammenfassung -- $t7 Transformationen: Konzeptionelle Fluchtlinien des Patientensubjekts im deutschen Gesundheitssystem -- $t7.1 Die Geburt des Versichertenpatienten: Versicherungstechnologie, Ärztepolitik und massenhaftes Kranksein -- $t7.2 Chronisch Kranksein: Chronische Krankheiten als ?normale Herausforderung? für die Medizin und die Politik der chronischen Erkrankungen -- $t7.3 Von der Versorgungspolitik der chronischen Erkrankungen zum Problem der seltenen chronischen Erkrankungen -- $t8 Die Politik der seltenen Erkrankungen als Politik der Kollektive -- $t8.1 (Politische) Patientensubjektkonzepte und seltene Erkrankungen: Eine relative theoretische Leerstelle -- $t8.2 Die Allianz Chronischer seltener Erkrankungen (ACHSE e.V.): Ein Dach für viele ?Seltene? -- $t8.3 Zusammenfassung -- $t9 Schluss -- $t9.1 Reflexion des wissenschaftlichen Vorgehens und zentrale Ergebnisse -- $t9.2 Ausblick -- $tAbkürzungsverzeichnis -- $tSchriftenverzeichnis -- $tAnhang 330 $aWie ist es möglich geworden, Patient*innen nicht nur als passiv und leidend, sondern auch als eigensinnig und politisch zu verstehen? Helene Gerhards verbindet genealogische und subjektkonstitutionsanalytische Zugänge, mit denen sie die Metamorphosen des Patient*innenseins im Spannungsfeld sozialer, ökonomischer, geschichtswissenschaftlicher und medizinischer Rationalitäten von der »Geburt der Klinik« bis heute nachverfolgt. Sie zeigt, wie sich Krankenversicherungsobjekte, antipsychiatrische Bewegungen und Organisationen im Feld seltener Erkrankungen formiert haben und argumentiert, dass Patient*innen erst zu Kollektiven werden mussten, um politische Zurechenbarkeit und Agentivität zu erlangen. 410 $aEdition Politik 606 $aPOLITICAL SCIENCE / History & Theory$2bisacsh 610 $aClinic. 610 $aCollective. 610 $aDemocracy. 610 $aIllness. 610 $aMedicine. 610 $aPolicy. 610 $aPolitical Science. 610 $aPolitical Theory. 610 $aPolitics. 610 $aSociety. 610 $aSociology of Medicine. 610 $aSubject Constitution. 615 7$aPOLITICAL SCIENCE / History & Theory. 676 $a362.1 700 $aGerhards$b Helene$4aut$4http://id.loc.gov/vocabulary/relators/aut$01251972 712 02$atranscript: Open Library 2022 (Politik)$4fnd$4http://id.loc.gov/vocabulary/relators/fnd 801 0$bDE-B1597 801 1$bDE-B1597 906 $aBOOK 912 $a9910585595203321 996 $aPatientenpolitiken$92902368 997 $aUNINA